Table 5 The over-represented classification of pathways for human identified genes
| Â | pathways | p value |
|---|---|---|
1 v 2 (0) | none | none |
2 v 4 (3) | hsa04540:Gap junction | 2.29E-03 |
| Â | hsa00100:Biosynthesis of steroids | 2.84E-03 |
| Â | hsa05060:Prion disease | 4.75E-03 |
4 v 8 (8) | hsa04110:Cell cycle | 3.37E-09 |
| Â | hsa04120:Ubiquitin mediated proteolysis | 1.44E-07 |
| Â | hsa04520:Adherens junction | 5.58E-06 |
| Â | hsa04115:p53 signaling pathway | 2.87E-04 |
| Â | hsa03022:Basal transcription factors | 8.31E-04 |
| Â | hsa00230:Purine metabolism | 4.87E-03 |
| Â | hsa05215:Prostate cancer | 4.99E-03 |
| Â | hsa00970:Aminoacyl-tRNA biosynthesis | 8.41E-03 |
8 v M (6) | hsa04120:Ubiquitin mediated proteolysis | 9.93E-05 |
| Â | hsa04110:Cell cycle | 1.58E-04 |
| Â | hsa05131: Eenteropathogenic E. coli (EPEC) infection | 3.82E-03 |
| Â | hsa05130: Enterohemorrhagic E. coli (EHEC) infection | 3.82E-03 |
| Â | hsa04115:p53 signaling pathway | 3.93E-03 |
| Â | hsa05221:Acute myeloid leukemia | 7.63E-03 |
M v B (11) | hsa00100:Biosynthesis of steroids | 2.26E-06 |
| Â | hsa05131: Eenteropathogenic E. coli (EPEC) infection | 5.82E-05 |
| Â | hsa05130: Enterohemorrhagic E. coli (EHEC) infection | 5.82E-05 |
| Â | hsa04120:Ubiquitin mediated proteolysis | 1.78E-04 |
| Â | hsa00251:Glutamate metabolism | 3.03E-04 |
| Â | hsa04520:Adherens junction | 7.05E-04 |
| Â | hsa00071:Fatty acid metabolism | 2.75E-03 |
| Â | hsa05110:Cholera - Infection | 2.93E-03 |
| Â | hsa00280:Valine, leucine and isoleucine degradation | 6.04E-03 |
| Â | hsa05211:Renal cell carcinoma | 6.26E-03 |
| Â | hsa00900:Terpenoid biosynthesis | 7.14E-03 |